Markets:

Overview

News

Currencies

International

Treasuries

Castle Biosciences, Inc. - Common stock (NQ:CSTL)

23.53 -1.03 (-4.19%)

Streaming Delayed Price Updated: 12:47 PM EDT, Jul 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Castle Biosciences, Inc. - Common stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Castle Biosciences to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

November 10, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Announces Third Quarter 2021 Results

November 08, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Releases Inaugural Environmental, Social and Governance (ESG) Report

November 08, 2021

From Castle Biosciences, Inc.

Via Business Wire

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm

November 05, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences’ Full DecisionDx® Portfolio of Dermatologic Tests to Be Interfaced with EMA® Electronic Health Records System

November 04, 2021

From Castle Biosciences, Inc.

Via Business Wire

DecisionDx®-Melanoma Integrated Test Result Now Includes i31-GEP for Risk of Recurrence

October 28, 2021

From Castle Biosciences, Inc.

Via Business Wire

New Data Demonstrating Accuracy of DecisionDx® DiffDx™-Melanoma Presented at ASDP 58th Annual Meeting

October 26, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences to Release Third Quarter 2021 Financial Results and Host Conference Call on Monday, Nov. 8, 2021

October 25, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Presents Data from Suite of Dermatologic Cancer Genomic Tests at Fall Clinical Dermatology Conference 2021

October 22, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences to Acquire Cernostics

October 19, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences President and CEO Derek Maetzold Will Deliver Keynote Presentation During Arizona Bioscience Week

September 28, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences's Return On Capital Employed Overview ↗

September 16, 2021

Castle Biosciences (NASDAQ:CSTL) brought in sales totaling $22.76 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 105.65%, resulting in a...

Via Benzinga

Castle Biosciences Announces New York Approval of DecisionDx® DiffDx™-Melanoma

September 16, 2021

From Castle Biosciences

Via Business Wire

Castle Biosciences Recognized as a Top 100 Healthcare Technology Company of 2021

August 30, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences to Present at Upcoming Investor Conferences

August 26, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma

August 24, 2021

From Castle Biosciences, Inc.

Via Business Wire

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

Castle Biosciences Presents New Data on DecisionDx®-Melanoma and DecisionDx®-SCC at the 2021 American Academy of Dermatology (AAD) Summer Meeting

August 16, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Q2 Earnings Edges Out Expectation On Record Test Report Volume ↗

August 10, 2021

After the market close on Monday, Castle Biosciences Inc (NASDAQ: CSTL) reported that its second-quarter revenues rose 79% Y/Y to $22.75 million, beating the...

Via Benzinga

Castle Biosciences Announces Second Quarter 2021 Results

August 09, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences to Present Data at the 2021 American Academy of Dermatology (AAD) Summer Meeting

August 06, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx®-SCC at the DERM2021 NP/PA CME Conference

August 05, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Collaborates with the Melanoma Research Foundation

August 02, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences to Participate at the Canaccord Genuity 41st Annual Growth Conference

July 28, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences to Release Second Quarter 2021 Financial Results and Host Conference Call on Monday, Aug. 9, 2021

July 26, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Presents New Data Demonstrating DecisionDx®-SCC Complements Current Risk Assessment Methods in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck

July 23, 2021

From Castle Biosciences, Inc.

Via Business Wire

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs ↗

July 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (...

Via Benzinga

Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx®-SCC at SDPA Annual Summer Dermatology Conference 2021

July 22, 2021

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Expands its Board of Directors with New Appointments

July 16, 2021

From Castle Biosciences, Inc.

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.